# Universal Hemoglobin A1c Versus Risk-based Screening for Early Gestational Diabetes Mellitus (EARLY GDM): A Randomized Controlled Trial

> **NCT06190405** · NA · UNKNOWN · sponsor: **Thomas Jefferson University** · enrollment: 770 (estimated)

## Conditions studied

- Gestational Diabetes
- Large for Gestational Age

## Interventions

- **DIAGNOSTIC_TEST:** Hemoglobin A1c
- **DIAGNOSTIC_TEST:** Risk-based screening by ACOG with two-step GTT

## Key facts

- **NCT ID:** NCT06190405
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01
- **Primary completion:** 2025-06
- **Final completion:** 2025-06
- **Target enrollment:** 770 (ESTIMATED)
- **Last updated:** 2024-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06190405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06190405, "Universal Hemoglobin A1c Versus Risk-based Screening for Early Gestational Diabetes Mellitus (EARLY GDM): A Randomized Controlled Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06190405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*